FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2893483832> ?p ?o ?g. }

• W2893483832 endingPage "491" @default.
• W2893483832 startingPage "479" @default.
• W2893483832 abstract "The use of synthetic cannabinoids causes similar effects as Δ9 -tetrahydrocannabinol and long-term (ab)use can lead to health hazards and fatal intoxications. As most investigated synthetic cannabinoids undergo extensive biotransformation, almost no parent compound can be detected in urine, which hampers forensic investigations. Limited information about the biotransformation products of new synthetic cannabinoids makes the detection of these drugs in various biological matrices challenging. This study aimed to identify the main in vitro biotransformation pathways of 5Cl-THJ-018 and to compare these findings with an authentic urine sample of a 5Cl-THJ-018 user. The synthetic cannabinoid was incubated with pooled human liver microsomes and cytosol to simulate phase I and phase II biotransformations. Resulting extracts were analyzed with liquid chromatography coupled to quadrupole time-of-flight mass spectrometry (LC-QTOF-MS). Three different data analysis workflows were applied to identify biotransformation products. A suspect screening workflow used an in-house database built from literature data and in silico biotransformation predictions. Two non-target screening workflows used a commercially available software and an open-source software for mass spectrometry data processing. A total of 23 in vitro biotransformation products were identified, with hydroxylation, oxidative dechlorination, and dihydrodiol formation pathways as the main phase I reactions. Additionally, five glucuronidated and three sulfated phase II conjugates were identified. The predominant in vivo pathway was through oxidative dechlorination and in total six metabolites of 5Cl-THJ-018 were identified. Biotransformation products both in vitro and in vivo were successfully identified using complementary suspect and non-target screening workflows." @default.
• W2893483832 created "2018-10-05" @default.
• W2893483832 creator A5009368419 @default.
• W2893483832 creator A5011966812 @default.
• W2893483832 creator A5012235532 @default.
• W2893483832 creator A5021401104 @default.
• W2893483832 creator A5042123511 @default.
• W2893483832 creator A5057356340 @default.
• W2893483832 creator A5073647450 @default.
• W2893483832 creator A5076082801 @default.
• W2893483832 creator A5084876348 @default.
• W2893483832 date "2018-10-23" @default.
• W2893483832 modified "2023-10-15" @default.
• W2893483832 title "Suspect and non-target screening workflows to investigate the <i>in vitro</i> and <i>in vivo</i> metabolism of the synthetic cannabinoid 5Cl-THJ-018" @default.
• W2893483832 cites W1517359192 @default.
• W2893483832 cites W1536445278 @default.
• W2893483832 cites W1753174715 @default.
• W2893483832 cites W1967001305 @default.
• W2893483832 cites W1986904152 @default.
• W2893483832 cites W1989299822 @default.
• W2893483832 cites W1990335454 @default.
• W2893483832 cites W2021178430 @default.
• W2893483832 cites W2024053795 @default.
• W2893483832 cites W2030526585 @default.
• W2893483832 cites W2040388672 @default.
• W2893483832 cites W2041841378 @default.
• W2893483832 cites W2043113964 @default.
• W2893483832 cites W2070099706 @default.
• W2893483832 cites W2074114778 @default.
• W2893483832 cites W2108046413 @default.
• W2893483832 cites W2148611011 @default.
• W2893483832 cites W2153539777 @default.
• W2893483832 cites W2186697446 @default.
• W2893483832 cites W2216389412 @default.
• W2893483832 cites W2322580831 @default.
• W2893483832 cites W2337155940 @default.
• W2893483832 cites W2407621641 @default.
• W2893483832 cites W2472043358 @default.
• W2893483832 cites W2530030091 @default.
• W2893483832 cites W2593385402 @default.
• W2893483832 cites W2604497858 @default.
• W2893483832 cites W2616295682 @default.
• W2893483832 cites W2743657619 @default.
• W2893483832 cites W2746594526 @default.
• W2893483832 cites W2792216441 @default.
• W2893483832 cites W2801605997 @default.
• W2893483832 cites W392491535 @default.
• W2893483832 cites W584367678 @default.
• W2893483832 doi "https://doi.org/10.1002/dta.2508" @default.
• W2893483832 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30242979" @default.
• W2893483832 hasPublicationYear "2018" @default.
• W2893483832 type Work @default.
• W2893483832 sameAs 2893483832 @default.
• W2893483832 citedByCount "17" @default.
• W2893483832 countsByYear W28934838322019 @default.
• W2893483832 countsByYear W28934838322020 @default.
• W2893483832 countsByYear W28934838322021 @default.
• W2893483832 countsByYear W28934838322022 @default.
• W2893483832 countsByYear W28934838322023 @default.
• W2893483832 crossrefType "journal-article" @default.
• W2893483832 hasAuthorship W2893483832A5009368419 @default.
• W2893483832 hasAuthorship W2893483832A5011966812 @default.
• W2893483832 hasAuthorship W2893483832A5012235532 @default.
• W2893483832 hasAuthorship W2893483832A5021401104 @default.
• W2893483832 hasAuthorship W2893483832A5042123511 @default.
• W2893483832 hasAuthorship W2893483832A5057356340 @default.
• W2893483832 hasAuthorship W2893483832A5073647450 @default.
• W2893483832 hasAuthorship W2893483832A5076082801 @default.
• W2893483832 hasAuthorship W2893483832A5084876348 @default.
• W2893483832 hasBestOaLocation W28934838322 @default.
• W2893483832 hasConcept C150903083 @default.
• W2893483832 hasConcept C162356407 @default.
• W2893483832 hasConcept C170493617 @default.
• W2893483832 hasConcept C181199279 @default.
• W2893483832 hasConcept C185592680 @default.
• W2893483832 hasConcept C202751555 @default.
• W2893483832 hasConcept C207001950 @default.
• W2893483832 hasConcept C2777846614 @default.
• W2893483832 hasConcept C2779907587 @default.
• W2893483832 hasConcept C2780871563 @default.
• W2893483832 hasConcept C2781109383 @default.
• W2893483832 hasConcept C27881333 @default.
• W2893483832 hasConcept C43617362 @default.
• W2893483832 hasConcept C55493867 @default.
• W2893483832 hasConcept C86803240 @default.
• W2893483832 hasConcept C87644729 @default.
• W2893483832 hasConceptScore W2893483832C150903083 @default.
• W2893483832 hasConceptScore W2893483832C162356407 @default.
• W2893483832 hasConceptScore W2893483832C170493617 @default.
• W2893483832 hasConceptScore W2893483832C181199279 @default.
• W2893483832 hasConceptScore W2893483832C185592680 @default.
• W2893483832 hasConceptScore W2893483832C202751555 @default.
• W2893483832 hasConceptScore W2893483832C207001950 @default.
• W2893483832 hasConceptScore W2893483832C2777846614 @default.
• W2893483832 hasConceptScore W2893483832C2779907587 @default.
• W2893483832 hasConceptScore W2893483832C2780871563 @default.
• W2893483832 hasConceptScore W2893483832C2781109383 @default.
• W2893483832 hasConceptScore W2893483832C27881333 @default.

• next